Faraj Tabrizi Pouriya, Zeuschner Philip, Katzendorn Olga, Schiefelbein Frank, Schneller Andreas, Schoen Georg, Ubrig Burkhard, Gloger Simon, Wiesinger Clemens G, Pfuner Jacob, Falkensammer Eva, Eraky Ahmed, Osmonov Daniar, Nuhn Philipp, Zimmermanns Volker, Paramythelli Ionna, Hadaschik Boris A, Radtke Jan P, Darr Christopher, Gilbert Nils, Kriegmair Maximilian, Fuhrmann Christian, Kuczyk Markus A, Harke Nina N
Hannover Medical School, Department of Urology and Urological Oncology, Hannover, Germany.
Department of Urology and Pediatric Urology, Saarland University, Homburg, Germany.
Minerva Urol Nephrol. 2024 Dec;76(6):698-707. doi: 10.23736/S2724-6051.24.05816-6. Epub 2024 Nov 28.
Robot-assisted partial nephrectomy (RAPN) is increasingly performed in challenging tumor constellations like multiple renal masses.
The objective was to investigate influencing factors on postoperative renal function (PRF) after ipsilateral robot-assisted partial nephrectomy of multiple tumors (iRAPN-MT). In this retrospective multicenter study, perioperative data of 132 trans- or retroperitoneal iRAPN-MT for ≥ two tumors were analyzed focusing on influencing factors on PRF and acute kidney injury including RIFLE and trifecta criteria. The impact of patient-, surgery- and tumor-related factors was investigated via uni- and multivariate regression analyses.
The majority of patients had two renal masses, with three or more lesions in 19%. Median operative time was 175 minutes. Eighty-five percent of the tumors were dissected on-clamp with a median cumulative warm ischemia time (WIT
iRAPN-MT for multiple ipsilateral renal masses is feasible with good trifecta rates. While mostly unmodifiable patient-associated parameters were independent predictors on PRF impairment, WIT
机器人辅助部分肾切除术(RAPN)越来越多地应用于处理具有挑战性的肿瘤情况,如多发性肾肿块。
目的是研究同侧机器人辅助多发性肿瘤部分肾切除术(iRAPN-MT)后影响术后肾功能(PRF)的因素。在这项回顾性多中心研究中,分析了132例经腹腔或腹膜后iRAPN-MT治疗≥两个肿瘤的围手术期数据,重点关注影响PRF和急性肾损伤的因素,包括RIFLE标准和三连胜标准。通过单因素和多因素回归分析研究患者、手术和肿瘤相关因素的影响。
大多数患者有两个肾肿块,19%有三个或更多病灶。中位手术时间为175分钟。85%的肿瘤在阻断下进行解剖,中位累计热缺血时间(WIT
iRAPN-MT治疗同侧多发性肾肿块是可行的,三连胜率良好。虽然大多数不可改变且与患者相关的参数是PRF损害的独立预测因素,但WIT